Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study

Avivit Cahn, Itamar Raz, Marc Bonaca, Ofri Mosenzon, Sabina A. Murphy, Ilan Yanuv, Aliza Rozenberg, John P.H. Wilding, Deepak L. Bhatt, Darren K. McGuire, Ingrid A.M. Gause-Nilsson, Martin Fredriksson, Peter A. Johansson, Gyorgy Jermendy, Samy Hadjadj, Anna Maria Langkilde, Marc S. Sabatine, Stephen D. Wiviott, Lawrence A. Leiter

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study'. Together they form a unique fingerprint.

Medicine & Life Sciences